Trial intelligence / Profile preview

NPB-01 in Multifocal Motor Neuropathy

NCT01827072Phase 3Completed

Sponsor
Nihon Pharmaceutical
Start
Apr 2013
Primary completion
Jun 2015
Modality
Biologic
Countries
1
01

Overview

A Phase 3 trial of NPB-01-ME in multifocal motor neuropathy (MMN), sponsored by Nihon Pharmaceutical. Started Apr 2013; status: completed.

02

Drugs

NPB-01-ME
03

Conditions

multifocal motor neuropathy (MMN)

Beyond the preview

Go deeper on NCT01827072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01827072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call